Nanotechnology strategies to advance outcomes in clinical cancer care
CM Hartshorn, MS Bradbury, GM Lanza, AE Nel… - ACS …, 2018 - ACS Publications
Ongoing research into the application of nanotechnology for cancer treatment and diagnosis
has demonstrated its advantages within contemporary oncology as well as its intrinsic …
has demonstrated its advantages within contemporary oncology as well as its intrinsic …
Escaping the endosome: assessing cellular trafficking mechanisms of non-viral vehicles
E Xu, WM Saltzman, AS Piotrowski-Daspit - Journal of Controlled Release, 2021 - Elsevier
Non-viral vehicles hold therapeutic promise in advancing the delivery of a variety of cargos
in vitro and in vivo, including small molecule drugs, biologics, and especially nucleic acids …
in vitro and in vivo, including small molecule drugs, biologics, and especially nucleic acids …
Recent applications and strategies in nanotechnology for lung diseases
W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
[HTML][HTML] Engineering tumor-targeting nanoparticles as vehicles for precision nanomedicine
As a nascent and emerging field that holds great potential for precision oncology,
nanotechnology has been envisioned to improve drug delivery and imaging capabilities …
nanotechnology has been envisioned to improve drug delivery and imaging capabilities …
[HTML][HTML] RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy
G Wang, Z Wang, C Li, G Duan, K Wang, Q Li… - Biomedicine & …, 2018 - Elsevier
One approach to improve the targeted therapeutic efficiency of lung cancer is to deliver
drugs using nano-scaled systems. In this study, RGD peptide-modified, paclitaxel (PTX) …
drugs using nano-scaled systems. In this study, RGD peptide-modified, paclitaxel (PTX) …
Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy
W Li, H Yu, D Ding, Z Chen, Y Wang, S Wang… - Free Radical Biology …, 2019 - Elsevier
Cold atmospheric plasma (CAP) is an emerging biomedical technique that shows great
potential for cancer treatment. On the other hand, magnetic nanoparticles open up a wide …
potential for cancer treatment. On the other hand, magnetic nanoparticles open up a wide …
Nanotechnology based therapeutics for lung disease
Nanomedicine is a multidisciplinary research field with an integration of traditional sciences
such as chemistry, physics, biology and materials science. The application of nanomedicine …
such as chemistry, physics, biology and materials science. The application of nanomedicine …
Multifunctional lipid-based nanoparticles for codelivery of anticancer drugs and siRNA for treatment of non-small cell lung cancer with different level of resistance and …
J Majumder, T Minko - Pharmaceutics, 2021 - mdpi.com
Resistance to chemotherapy, enhanced proliferation, invasion, angiogenesis, and
metastasis (RPIAM) represent major obstacles that limit the efficacy of cancer treatment …
metastasis (RPIAM) represent major obstacles that limit the efficacy of cancer treatment …
Self‐assembled nanomedicines for anticancer and antibacterial applications
L Zhou, T Qiu, F Lv, L Liu, J Ying… - Advanced Healthcare …, 2018 - Wiley Online Library
Self‐assembly strategies have been widely applied in the nanomedicine field, which provide
a convenient approach for building various structures for delivery carriers. When …
a convenient approach for building various structures for delivery carriers. When …
Lung cancer and metastasis: new opportunities and challenges
X Wang, AA Adjei - Cancer and Metastasis Reviews, 2015 - Springer
Lung cancer continues to attract special attention since the real number of lung cancer
mortality and incidence in 2014 was definitely higher than those estimated numbers …
mortality and incidence in 2014 was definitely higher than those estimated numbers …